Abstract:Cancer cells recruit immune cells to the solid tumor tissue, which can either promote or inhibit the progression. Studies in mice suggest that polarizing neutrophils from a pro-tumor (N2) phenotype to an anti-tumor (N1) phenotype may serve as a promising strategy for immunotherapy. Understanding the mechanisms by which N1 and N2 human neutrophil subpopulations interact with cancer cells and influence the tumor microenvironment (TME) is important for solid tumor immunotherapy in the clinic. It is difficult to monitor immune cell-cancer interactions in the human TME. Microphysiological models are microfluidic platforms that consist of cells, explants, spheroids, or organoids to study pathological processes with single-cell resolution. In this study, we engineered a human cell-based microphysiological system to quantify the interactions of N1 and N2 human neutrophils with pancreatic tumor spheroids. LPS, IFN-γ, and IFN-β-polarized N1-like or TGF-β-polarized N2-like HL-60 human neutrophils and PANC-1 tumor spheroids were embedded in 3D collagen hydrogel mimicking the extracellular matrix of the tumor tissue and loaded into the polydimethylsiloxane- fabricated microfluidic system. Time-lapse epifluorescence imaging and end-point confocal imaging were performed to capture neutrophil motility, contact with, and infiltration into tumor spheroids. We first confirmed that N1-like neutrophils were CD11bhigh/CD54high/CD62Llow/CXCR2low and that N2-like neutrophils were CD11bhigh/CD54low/CD62Lhigh/CXCR2high using flow cytometry. We then validated that N1-like neutrophils showed higher levels of ROS production, IL-8 secretion, and NET release than N2-like neutrophils (p<0.0001). When challenged with tumor spheroids in the system, N2-like neutrophils showed a higher motility than N1-like neutrophils in speed (3.23 vs. 1.68 μm/min, p<0.0001), directionality (0.29 vs. 0.26, p<0.01), and displacement (31.60 vs. 18.08 μm, p 0.99), N1-like neutrophils showed a longer duration of contact than N2-like neutrophils (32.7 vs. 20.3 min, p<0.0001). We found a higher number of N1-like neutrophils that infiltrated into tumor spheroids than N2-like neutrophils (4.6 vs. 3.0 cells/spheroid, p=0.01), although the infiltration depth was similar (7.4 vs. 6.0 μm, p=0.36). 2D co-cultures showed that N1-like neutrophils induced apoptosis of PANC-1 cancer cells, while N2-like neutrophils attenuated chemotherapy-induced cancer cell apoptosis (p<0.0001). The system also enabled us to measure the effect of N1-like and N2-like neutrophils on the apoptosis, proliferation (Ki-67), and epithelial-mesenchymal transition (vimentin) of tumor spheroids. Our research sheds light on the "behaviorome" of human neutrophil subpopulations in cancer. Our microphysiological model will serve as a complementary tool to animal models for mechanistic studies, immunotherapy testing, and personalized medicine using patient-derived cells. Citation Format: Shuai Shao, Daniel Duncko, Caroline N Jones. A microphysiological system to quantify the interactions of human neutrophil subpopulations with pancreatic tumor spheroids [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy; 2024 Oct 18-21; Boston, MA. Philadelphia (PA): AACR; Cancer Immunol Res 2024;12(10 Suppl) nr A041.

Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice

Therapeutic Effect of MIP-1alpha-recruited Dendritic Cells on Preestablished Solid and Metastatic Tumors.

Intratumoral Expression of Mature Human Neutrophil Peptide-1 Potentiates the Therapeutic Effect of Doxorubicin in a Mouse 4T1 Breast Cancer Model

A small cytotoxic peptide from frog elicits potent antitumor immunity to prevent local tumor growth and metastases.

Human Α-Defensin-1 Inhibits Growth of Human Lung Adenocarcinoma Xenograft in Nude Mice

Preclinical Safety Evaluation of a Recombinant Plasmid Vector Encoding Mature Human Neutrophil Peptide-1 by Repeated Local Administrations in Nonhuman Primates

Regulation of Activities of NK Cells and CD4 Expression in T Cells by Human HNP-1, -2, and -3.

A Modified HLA-A*0201-restricted CTL Epitope from Human Oncoprotein (hpebp4) Induces More Efficient Antitumor Responses

Hainanenin-1, an oncolytic peptide, triggers immunogenic cell death via STING activation in triple-negative breast cancer

Host genetics and tumor environment determine the functional impact of neutrophils in mouse tumor models

Small peptides elicit anti-tumor effects in CT26 model through blocking PD-L1/PD-1 (TUM2P.900)

Targeted Delivery of Tumor Antigens to Activated Dendritic Cells Via CD11c Molecules Induces Potent Antitumor Immunity in Mice

Immune sculpting of norepinephrine on MHC-I, B7-1, IDO and B7-H1 expression and regulation of proliferation and invasion in pancreatic carcinoma cells.

Single-cell RNA sequencing reveals anti-tumor potency of CD56+ NK cells and CD8+ T cells in humanized mice via PD-1 and TIGIT co-targeting

Administration of MIP-3alpha Gene to the Tumor Following Radiation Therapy Boosts Anti-Tumor Immunity in a Murine Model of Lung Carcinoma.

Abstract A041: A microphysiological system to quantify the interactions of human neutrophil subpopulations with pancreatic tumor spheroids

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Tumor-Microenvironment-Activatable Nanoparticle Mediating Immunogene Therapy and M2 Macrophage-Targeted Inhibitor for Synergistic Cancer Immunotherapy.

Abstract 5345: Development and validation of humanized HLA mouse model platforms for preclinical evaluation of novel peptide vaccines

A microphysiological system reveals neutrophil contact-dependent attenuation of pancreatic tumor progression by CXCR2 inhibition-based immunotherapy

Tumor MHC Class I Expression Alters Cancer-Associated Myelopoiesis Driven by Host NK Cells.